Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy and chronic hepatitis B virus infection. (Source: Yahoo Finance)
On April 15, 2020, the Company completed the re-domiciliation of the Company from Australia to the United States. As a result, the Company is now incorporated in the United States and its common stock is listed on Nasdaq. (Source: prnewswire.com)
Market Cap 17.093M
Please leave me a message if you want to test the buy and sell indicators that i am using.
On April 15, 2020, the Company completed the re-domiciliation of the Company from Australia to the United States. As a result, the Company is now incorporated in the United States and its common stock is listed on Nasdaq. (Source: prnewswire.com)
Market Cap 17.093M
Please leave me a message if you want to test the buy and sell indicators that i am using.
Copy my trades: partner.bybit.com/b/best_copy_trading
BUY-SELL INDICATORS: bit.ly/indicatorz
TRADING COURSE: bit.ly/10Xtrading
STOCK OPTIONS SIGNALS: bit.ly/options_signals
BUY-SELL INDICATORS: bit.ly/indicatorz
TRADING COURSE: bit.ly/10Xtrading
STOCK OPTIONS SIGNALS: bit.ly/options_signals
Exención de responsabilidad
La información y las publicaciones que ofrecemos, no implican ni constituyen un asesoramiento financiero, ni de inversión, trading o cualquier otro tipo de consejo o recomendación emitida o respaldada por TradingView. Puede obtener información adicional en las Condiciones de uso.
Copy my trades: partner.bybit.com/b/best_copy_trading
BUY-SELL INDICATORS: bit.ly/indicatorz
TRADING COURSE: bit.ly/10Xtrading
STOCK OPTIONS SIGNALS: bit.ly/options_signals
BUY-SELL INDICATORS: bit.ly/indicatorz
TRADING COURSE: bit.ly/10Xtrading
STOCK OPTIONS SIGNALS: bit.ly/options_signals
Exención de responsabilidad
La información y las publicaciones que ofrecemos, no implican ni constituyen un asesoramiento financiero, ni de inversión, trading o cualquier otro tipo de consejo o recomendación emitida o respaldada por TradingView. Puede obtener información adicional en las Condiciones de uso.